首页> 美国卫生研究院文献>The Journal of Clinical Investigation >ER stress regulates myeloid-derived suppressor cell fate throughTRAIL-R–mediated apoptosis
【2h】

ER stress regulates myeloid-derived suppressor cell fate throughTRAIL-R–mediated apoptosis

机译:内质网应激通过以下途径调节髓样抑制细胞的命运TRAIL-R介导的细胞凋亡

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Myeloid-derived suppressor cells (MDSCs) dampen the immune response thorough inhibition of T cell activation and proliferation and often are expanded in pathological conditions. Here, we studied the fate of MDSCs in cancer. Unexpectedly, MDSCs had lower viability and a shorter half-life in tumor-bearing mice compared with neutrophils and monocytes. The reduction of MDSC viability was due to increased apoptosis, which was mediated by increased expression of TNF-related apoptosis–induced ligand receptors (TRAIL-Rs) in these cells. Targeting TRAIL-Rs in naive mice did not affect myeloid cell populations, but it dramatically reduced the presence of MDSCs and improved immune responses in tumor-bearing mice. Treatment of myeloid cells with proinflammatory cytokines did not affect TRAIL-R expression; however, induction of ER stress in myeloid cells recapitulated changes in TRAIL-R expression observed in tumor-bearing hosts. The ER stress response was detected in MDSCs isolated from cancer patients and tumor-bearing mice, but not in control neutrophils or monocytes, and blockade of ER stress abrogated tumor-associated changes in TRAIL-Rs. Together, these data indicate that MDSC pathophysiology is linked to ER stress, which shortens the lifespan of these cells in the periphery and promotes expansion in BM. Furthermore, TRAIL-Rs can be considered as potential targets for selectively inhibiting MDSCs.
机译:骨髓来源的抑制细胞(MDSCs)通过抑制T细胞的活化和增殖来减弱免疫反应,并且经常在病理条件下扩展。在这里,我们研究了MDSCs在癌症中的命运。出乎意料的是,与嗜中性粒细胞和单核细胞相比,MDSCs在荷瘤小鼠中的活力较低,半衰期较短。 MDSC活力的降低归因于凋亡增加,这是由这些细胞中TNF相关凋亡诱导的配体受体(TRAIL-Rs)表达的增加介导的。在幼稚的小鼠中靶向TRAIL-Rs不会影响髓样细胞群体,但可显着减少MDSCs的存在并改善荷瘤小鼠的免疫反应。用促炎细胞因子处理髓样细胞不影响TRAIL-R的表达。然而,在髓样细胞中ER应激的诱导概括了在荷瘤宿主中观察到的TRAIL-R表达的变化。在分离自癌症患者和荷瘤小鼠的MDSCs中检测到ER应激反应,但在对照中性粒细胞或单核细胞中未检测到,并且ER应激的阻断消除了TRAIL-Rs中与肿瘤相关的变化。总之,这些数据表明MDSC病理生理学与内质网应激有关,这缩短了这些细胞在外周的寿命并促进了BM的扩增。此外,可以将TRAIL-R视为选择性抑制MDSC的潜在靶标。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号